FindTrial
Sign In

Research on the Mechanism of Akkermansia muciniphila in Reducing Inflammation in Crohn's Disease

Research on the Mechanism of Akkermansia muciniphila in Reducing Inflammation in Crohn's Disease

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500114740
Enrollment
Unknown
Registered
2025-12-17
Start date
2026-01-01
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inflammatory bowel disease

Interventions

Inflammatory bowel disease group:None

Sponsors

The First Affiliated Hospital with Nanjing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Patients diagnosed with CD according to the "Diagnosis and Treatment Guidelines for Inflammatory Bowel Disease"

Exclusion criteria

Exclusion criteria: Exclude those with pregnancy, autoimmune diseases, hematological diseases, malignant tumors, chronic liver and kidney diseases, and those with severe heart, brain and lung diseases

Design outcomes

Primary

MeasureTime frame
Akk Bacterial abundance;—

Countries

China

Contacts

Public ContactZhang Hong-Jie

The First Affiliated Hospital with Nanjing Medical University

hjzhang06@163.com+86 25 6830 3472

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026